Moneycontrol PRO
Black Friday Sale
Black Friday Sale
HomeNewsBusinessStocksStocks in the news: Alkem, Healthcare, OM Metal, IL&FS Transportation, Escorts

Stocks in the news: Alkem, Healthcare, OM Metal, IL&FS Transportation, Escorts

Alkem Labs | Shilpa Medicare | Healthcare Global | Nestle | Indowind Energy | OM Metals Infra | V-Guard | IL&FS Transportation | National Peroxide | Ashok Leyland | Escorts | JSW Steel and Sanofi are stocks, which are in the news today.

March 29, 2017 / 09:14 IST
Here are stocks that are in news today:

Cabinet to consider mega power policy today: Sources

-Mega power policy to allow extension of 5 years for power projects to sign PPAs

-Extension to allow power companies to enjoy customs & import duty benefits

-Power purchase agreement & bank guarantee to be in proportion for power projects

NPA resolution: Sources

-Finance ministry to meet banks, RBI officials to discuss NPA (non-performing assets) resolution this week

-Large stressed accounts to be taken up for resolution in meet

-Stressed accounts of Essar Steel, Bhushan Steel may be on agenda

-Stressed accounts of Alok Industries, other power projects may be on agenda

-Decision-making mechanism for large stressed accounts likely to be set up

-Move to help banks write-off debt without fear of investigation

-Government to give clarity on funding of NPA accounts for revival of company

-May relax limit of working capital to be provided by the banks

US FDA observations: Alkem Labs' Baddi unit

-Written testing stability programme on several drugs not completed in time

-Production, control records lack complete manufacturing & control instructions, special notifications

-No written procedure for production & process controls designed

Alert: US FDA inspected Baddi unit from March 2-10

Other stocks and sectors that are in news today:

-Millitoons Entertainment's bonus shares to list today

-Sundram Fasteners acquired 16.8 lakh shares of subsidiary from Bleistahl Produktions

-IL&FS Engineering redeemed OCCRPS (optionally convertible cumulative redeemable preference shares) worth Rs 50 crore and CRPS (cumulative redeemable preference shares) worth Rs 3 crore

-Shilpa Medicare says shareholder meeting on April 29 to consider amalgamation of Navya Biologicals with self

-Healthcare Global entered into special purchase agreement (SPA) for a proposed investment in Cancer Care Kenya

-Autolite converted 6 lakh warrants into 6 lakh equity shares

-Nestle Munch partners with Baahubali 2

-Balasore Alloys board meeting on March 31 for allotment of 1 crore shares in lieu of 1 crore warrants to promoters

-Indowind Energy successfully completed powering of 1.92MW wind farm capacity in Karnataka and make change of 3.025MW in Tamil Nadu

-OM Metals Infra gets letter of intent from Indra Sagar Project for Rs 13.5 crore

-V-Guard approved investment in GUTS Electro-mech

-Emmbi inaugurates world's widest width pond lining facility at Silvassa

-IL&FS Transportation to refinance road assets worth Rs 9,000 crore

-Enforcement Directorate attaches assets worth Rs 263 crore of Deccan Chronicle

-Wadias to buy out Solvay's 25 percent stake in National Peroxide

-Ashok Leyland to invest Rs 400 crore on light commercial vehicle development

-Escorts to drive tractors to new markets, cut costs

-JSW Steel considers issuing of debt instruments in form of dollar-denominated senior notes

-Sanofi Gets US FDA nod for Dupilumab injection (used to treat moderate-to-severe atopic dermatitis)

-Dilip Buildcon declared lowest bidder for NHAI orders worth Rs 503.1 crore in Andhra Pradesh

first published: Mar 29, 2017 08:16 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347